Relationship of myocardial perfusion imaging findings to outcome of patients with heart failure and suspected ischemic heart disease

American Heart Journal

Volumn 147, Issue 4, 2004, Pages 714-720

  Miller, Wayne L ^a   Hodge, David O ^a   Tointon, Susan K ^a   Rodeheffer, Richard J ^a   Nelson, Susan M ^a   Gibbons, Raymond J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TECHNETIUM 99M; THALLIUM 201;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART PERFUSION; HUMAN; IMAGING; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVASCULARIZATION; SCINTIGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SURVIVAL; TREATMENT OUTCOME;

AGED; FEMALE; FOLLOW-UP STUDIES; GATED BLOOD-POOL IMAGING; HEART; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; MYOCARDIAL REVASCULARIZATION; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; STROKE VOLUME; TECHNETIUM TC 99M SESTAMIBI; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENTRICULAR DYSFUNCTION, LEFT;

EID: 3142546773     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ahj.2003.10.045     Document Type: Article

References (40)

1. Gheorghiade M., Bonow R.O. Chronic heart failure in the United States A manifestation of coronary artery disease. Circulation. 97:1998;282-289
2. Bart B.A., Shaw L.K., McCants C.B., et al. The clinical and angiographic diagnosis of ischemic cardiomyopathy A need to reassess our diagnostic criteria. Circulation. 94:(Suppl I):1996;I-338. [abstract]
3. Bart B.A., Shaw L.K., McCants C.B. Jr, et al. Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy. J Am Coll Cardiol. 30:1997;1002-1008
4. Lee K.S., Marwick T.H., Cook S.A., et al. Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction Relative efficacy of medical therapy and revascularization. Circulation. 90:1994;2687-2694
5. Beanlands R.S.B., Hendry P.J., Masters R.G., et al. Delay in revascularization is associated with increased mortality rate in patients with severe left ventricular dysfunction and viable myocardium on fluorine 18 fluorodeoxyglucose positron emission tomography imaging. Circulation. 98:1998;II-51-56
6. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med. 316:1987;1429-1435
7. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 325:1991;293-302
8. Packer M., Bristow M.R., Cohn J.N., et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med. 334:1996;1349-1355
9. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet. 353:1999;2001-2007
10. Pitt B., Zannad F., Remme W.J., et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med. 341:1999;709-717
11. Williams J.F., Bristow M.R., Fowler M.B., et al. ACC/AHA Task Force Report. Guidelines for the evaluation and management of heart failure. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure). J Am Coll Cardiol. 92:1995;2764-2784
12. Baker D.W., Jones R., Hodges J., et al. Management of heart failure. III. The role of revascularization in the treatment of patients with moderate or severe left ventricular systolic dysfunction. JAMA. 272:1994;1528-1534
13. Heart Failure Guideline Panel. Evaluation and care of patients with left ventricular systolic dysfunction. Rockville, MD: US Department of Health and Human Services, Agency for Health Care Policy and Research 1994. Clinical Practice Guideline Number 11. AHCPR Publication 94-0612
14. Task Force for the Working Group on Hart Failure of the European Society of Cardiology. The treatment of heart failure. Eur Heart J. 18:1997;736-753
15. Wijns W., Vatner S.F., Camici P.G. Hibernating myocardium. N Engl J Med. 339:1998;173-181
16. Dilsizian V., Rocco T.P., Freedman N.M.T., et al. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med. 323:1990;141-146
17. Gioia G., Powers J., Heo J., et al. Prognostic value of rest-redistribution tomographic thallium-201 imaging in ischemic cardiomyopathy. Am J Cardiol. 75:1995;759-762
18. Ragosta M., Beller G., Watson D., et al. Quantitative planar rest-redistribution 201 Tl imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function. Circulation. 87:1993;1630-1641
19. Pasquet A., Robert A., D'Hondt A.M., et al. Prognostic value of myocardial ischemia and viability in patients with chronic left ventricular ischemic dysfunction. Circulation. 100:1999;141-148
20. Kitsiou A.N., Srinivasan G., Quyyumi A.A., et al. Stress-induced reversible and mild-to-moderate irreversible thallium defects Are they equally accurate for predicting recovery of regional left ventricular function after revascularization? Circulation. 98:1998;501-508
21. Pagley P.R., Beller G.A., Watson D.D., et al. Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability. Circulation. 96:1997;793-800
22. Samady H, Elefteriades JA, Abbott BG, et al. Failure to improve left ventricular function after coronary revascularization for ischemic cardiomyopathy is not associated with worse outcome. Circulation 1999;1298-304
23. Mickborough L.L., Maruyama H., Takagi Y., et al. Results of revascularization in patients with severe left ventricular dysfunction. Circulation. 92:(Suppl II):1995;II-7-9
24. Marwick T.H., Zuchowski C., Lauer M.S., et al. Functional status and quality of life in patients with heart failure undergoing coronary bypass surgery after assessment of myocardial viability. J Am Coll Cardiol. 33:1999;750-758
25. Senior R., Kaul S., Lahiri A. Myocardial viability on echocardiography predicts long-term survival after revascularization in patients with ischemic congestive heart failure. J Am Coll Cardiol. 33:1999;1848-1854
26. Bax J.J., Poldermans D., Elhendy A., et al. Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography. J Am Coll Cardiol. 34:1999;163-169
27. Monin J.L., Garot J., Scherrer-Crosbie M., et al. Prediction of functional recovery of viable myocardium after delayed revascularization in postinfarction patients. J Am Coll Cardiol. 34:1999;1012-1019
28. Di Carli M.F., Asgarzadie F., Schelbert H.R., et al. Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. Circulation. 92:1995;3436-3444
29. Kozman H., Cook J.R., Wiseman A.H., et al. Presence of angiographic coronary collaterals predicts myocardial recovery after coronary bypass surgery in patients with severe left ventricular dysfunction. Circulation. 98:1998;II-57-61
30. Elefteriades J.A., Tolis G. Jr, Levi E., et al. Coronary artery bypass grafting in severe left ventricular dysfunction Excellent survival with improved ejection fraction and functional state. J Am Coll Cardiol. 22:1993;1411-1417
31. Miller W.L., Tointon S.K., Hodge D.O., et al. Long-term outcome and the use of revascularization in patients with heart failure, suspected ischemic heart disease, and large reversible myocardial perfusion defects. Am Heart J. 143:2002;904-909
32. Wagdy H.M., Hodge D., Christian T.M., et al. Prognostic value of vasodilator myocardial perfusion imaging in patients with left bundle branch block. Circulation. 97:1998;1563-1570
33. Auerbach M.A., Schoder H., Hoh C., et al. Prevalence of myocardial viability as detected by positron emission tomography in patients with ischemic cardiomyopathy. Circulation. 99:1999;2921-2926
34. Christian T.F., Miller T.D., Hodge D.O., et al. An estimate of the prevalence of reversible left ventricular dysfunction in patients referred for coronary artery bypass surgery. J Nucl Cardiol. 4:1996;140-146
35. Go R.T., MacIntyre W.J., Cook S.A., et al. The incidence of scintigraphically viable and nonviable tissue by rubidium-82 and fluorine-18-fluorodeoxyglucose positron emission tomographic imaging in patients with prior infarction and left ventricular dysfunction. J Nucl Cardiol. 3:1996;96-104
36. Meluzin J., Cerny J., Spinarova L., et al. Prognosis of patients with chronic coroanry artery disease and severe left ventricular dysfunction The importance of myocardial viability. Eur J Heart Failure. 5:2003;85-93
37. Allman K.C., Shaw L.J., Hachamovitch R., et al. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction A meta-analysis. J Am Coll Cardiol. 39:2002;1151-1162
38. Bourque J.M., Velazquez E.J., Borges-Neto S., et al. Radionuclide viability testing Should it affect treatment strategy in patients with cardiomyopathy and significant coronary artery disease? Am Heart J. 145:2003;758-767
39. Gibbons R.J., Hodge D.O., Berman D.S., et al. Long-term outcome of patients with intermediate-risk exercise electrocardiograms who do not have myocardial perfusion defects on radionuclide imaging. Circulation. 100:1999;2140-2145
40. 99mTc-sestamibi A measure of the efficacy of therapy in acute myocardial infarction. Circulation. 101:2000;101-108